Neuroblastoma is one of the most common cancers in infants and young children, and is rarely found in children older than 10 years of age. It is a cancer of immature nerve cells and can occur anywhere in the body but most often occurs in the adrenal glands within the abdomen. The treatment of Neuroblastoma depends on many factors such as the age of the child at diagnosis, the stage of the tumor and the presence of certain biological characteristics. A major goal of current neuroblastoma research is the precise assessment of each individual patient at diagnosis to select the optimal treatment. One way to assess patients is by their response to treatment and markers for following the response to therapy are needed to find the optimal treatment strategy for each individual patient.
The Center is collecting samples from Neuroblastoma patients and of healthy children, which are used as controls in a clinical trial at Riley Hospital for Children. Throughout chemotherapy and for several months afterwards, a small amount of extra blood is collected each time blood is routinely drawn. For more information please contact Joy Rupenthal at (317) 274-4415.